Cite

HARVARD Citation

    Feng, F. et al. (n.d.). 754PTargeted therapy based on the genetic alterations prolongs the progression-free survival of patients with advanced biliary tract cancer. Annals of oncology. p. . [Online]. 
  
Back to record